# Cochlear Implantation in Down Syndrome: Functional Outcomes, Challenges, and Management Strategies

**Authors:** David H. Elisha, David H. Cohen, Andrea Monterrubio, Ryan Hossain, Nicholas DiStefano, Rahul Mittal, Adrien A. Eshraghi

PMC · DOI: 10.3390/audiolres16020044 · 2026-03-09

## TL;DR

Cochlear implants can improve hearing and communication in children with Down syndrome, but success depends on early implantation and managing anatomical and cognitive challenges.

## Contribution

This study systematically reviews cochlear implant outcomes in Down syndrome patients, highlighting the importance of preoperative imaging and individualized care.

## Key findings

- CI improved audiometric results and psychosocial outcomes in children with Down syndrome.
- Early implantation and preoperative imaging (CT/MRI) were linked to better outcomes.
- Cognitive limitations and anatomical issues like cochlear nerve hypoplasia affected variability in results.

## Abstract

Objective: The aim was to evaluate cochlear implantation (CI) outcomes in children with Down syndrome (DS) with severe-to-profound sensorineural hearing loss (SNHL), addressing a literature gap and discussing challenges including anatomical abnormalities, cognitive deficits, and Eustachian tube dysfunction. Data Sources: Systematic searches were conducted in PubMed, Web of Science, Scopus, and Embase from inception through to June 2025. Review Methods: A systematic review adhering to PRISMA guidelines was performed. Included studies reported CI outcomes in DS patients receiving otolaryngologic care for SNHL. Extracted data included findings on ear anatomy, auditory performance, speech/language development, intelligibility, and duration of CI use. Results: A total of 149 abstracts were screened, yielding six studies with 26 patients that met the inclusion criteria. The review included pediatric DS patients with documented ages at implantation spanning from 11 months to 17.9 years. CI provided significant benefits for DS patients, including improved audiometric results, enhanced environmental awareness, and psychosocial gains. Optimal outcomes were associated with early implantation, thorough preoperative imaging (CT/MRI), and management of middle ear disease. Variability in outcomes often reflected cognitive limitations and anatomical challenges such as cochlear nerve hypoplasia and Eustachian tube dysfunction. Conclusions: CI can significantly improve quality of life and communication in children with DS when tailored to their unique needs. Preoperative imaging is essential to assess candidacy, and middle ear disease should be addressed prior to surgery. Clinicians should counsel families with individualized goals that emphasize functional hearing gains over normative speech benchmarks. Broader adoption of CI in this population may be supported by standardized, population-sensitive outcome measures and future prospective studies.

## Linked entities

- **Diseases:** Down syndrome (MONDO:0008608), sensorineural hearing loss (MONDO:0010576)

## Full-text entities

- **Diseases:** malformations (MESH:C564254), ear malformations (MESH:D004427), cochlea, CN (MESH:D000160), intellectual disabilities (MESH:D008607), stenosis of the internal auditory canal (MESH:D016893), CI (MESH:D015834), cognitive and intellectual impairments (MESH:D003072), , external, middle and inner ear malformations (MESH:D007759), OME (MESH:D010034), hypoplastic (MESH:D000741), CAP (MESH:D006311), cholesteatoma (MESH:D002781), VT (MESH:D053717), CHL (MESH:D006314), Hearing Loss (MESH:D034381), Down Syndrome"[MeSH (MESH:D006258), congenital syndromes (MESH:D008209), tympanic membrane (TM) perforations (MESH:D018058), Branchio-oto-renal (MESH:D019280), Chromosome 21 Trisomy (MESH:D004314), AOM (MESH:C537492), dehiscence of the facial nerve (MESH:D005155), EVA (OMIM:600791), acute otitis media (MESH:D010033), deformities of the (MESH:D009140), postoperative infections (MESH:D013530), SNHL (MESH:D006319), aplasia (MESH:C536482), infection (MESH:D007239), anatomical abnormalities (MESH:D020763), ET (MESH:D005184), EAC (MESH:C566245), injury to (MESH:D014947), developmental delay (MESH:D002658), effusion (MESH:D000080324), canal (MESH:D056735), dry (MESH:D015352), malformations of the SCC (MESH:D000084322), CHARGE (MESH:D058747), otorrhea (MESH:D002558), structural abnormalities (MESH:C566527), Deafness (MESH:D003638), temporal bone malformations (MESH:D001847)
- **Chemicals:** BioRender (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13010643/full.md

---
Source: https://tomesphere.com/paper/PMC13010643